TB Vaccines as Therapy in Latently Infected HIV+ Adults- Tom Evans (Aeras)

Update on TB Vaccines and Implication for TB/HIV- Stefan Kaufmann (Max Planck Institute)Подробнее

Session 2 - TB HIV 2019 Willem HanekomПодробнее

What Are The Challenges Associated With Treating TB in HIV-Infected Patients?Подробнее

What’s New—and Next—for TB VaccinesПодробнее

Tuberculosis VaccineПодробнее

HIVR4P // Virtual SA03 HIV & TB: An R&D tale of two vaccines (Part 1/3)Подробнее

TB vaccine updateПодробнее

HIVR4P // Virtual SA03 HIV & TB: An R&D tale of two vaccines (Part 2/3)Подробнее

Panel: How to Change the Tide for TB/HIV-Moderators: Jerry Ellner, Sarah FortuneПодробнее

Vaccines for the HIV-infected Patient 2.0Подробнее

Novel vaccines to prevent tuberculosis - Thomas EvansПодробнее

Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected ...Подробнее

Vaccines for the HIV-infected Patient 2013Подробнее

Aeras: Advancing Tuberculosis Vaccines for the WorldПодробнее

From biomarkers to vaccines: how immunology can help end TBПодробнее

TB VaccinesПодробнее

Vaccines for adults with HIV infectionПодробнее

Dr. Tom Frieden addresses vaccine hesitancy, and role of politics | COVID-19 Update for May 10, 2021Подробнее

Improving the efficiency of cancer vaccines with adoptive T cell therapy approachesПодробнее